Advanced Technologies Core
Advanced Technologies Core
批准号:
9111795
负责人:
Roger Keith Reeves
金额:
$33.25万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2019-07-31
关键词:
Acquired Immunodeficiency SyndromeAreaBiocompatible MaterialsBostonCell SeparationCellsCloud ComputingCollaborationsCommunitiesComputing MethodologiesContainmentDana-Farber Cancer InstituteDataData SetDevelopmentDiseaseEmerging TechnologiesEnsureEpigenetic ProcessEquipmentEvaluationFlow CytometryFosteringGeneral HospitalsGenomicsHealthHospitalsHumanImageImaging technologyImmunologicsImmunologyIndividualInstitutesInstitutionInstructionInternetIsraelLaboratoriesMassachusettsMedicalMedical centerMicroscopyMissionMolecular BiologyPediatric HospitalsPreventive InterventionProceduresProtocols documentationPublic Health SchoolsResearchResearch DesignResearch PersonnelResourcesSamplingServicesSiteSorting - Cell MovementSpecimenStandardizationStructureTargeted ResequencingTechnologyTherapeutic InterventionTimeTissuesTrainingUniversitiesViralWomanbasecytokineindexingmedical schoolsmembernew technologyonline communityperipheral bloodsymposiumtooltranscriptome sequencingtranscriptomicsvaccine developmentvirus host interaction
中文摘要
HU CFAR的最大附加值之一是加速了成员获得新的和
新兴技术。在前两个竞争提交中,这些技术主要是
通过分子生物学和基因组学核心和免疫学核心提供。提供的服务
主要集中在基因组和流式细胞技术上,并随着时间的推移而不断发展,继续
向成员提供个别调查员无法获得的支助。基于我们
2012年CFAR战略审查,成员们得出结论认为,通过整合这些核心,
先进的免疫学和基因组学技术的交叉和日益增长的计算能力,
与此相关的挑战,我们可以更好地利用CFAR资源为成员服务。这两
因此,这些核心被合并并重新定义,以形成单个高级技术核心(ATC)。整体
新的先进技术核心的使命是提供先进的细胞计数/基因组
技术和计算方法是一个越来越具有挑战性的障碍,个人
investigators.目前,已确定的成员需求主要是获取信息
关于单个细胞的表型和功能状态,索引这些样品,然后
利用这一珍贵的生物材料来开发一个全面的基因组景观,
存在于特定的疾病状态中。为了确保所有哈佛CFAR实验室都能使用这个
这一核心具有非凡的分析能力,将通过以下目标促进获得此类技术:
1)为CFAR成员提供最先进的技术。
2)提供上述技术的用户培训以及计算协助。
3)使用最先进的共享和分发工具构建虚拟社区。
英文摘要
One of the greatest added values of the HU CFAR has been accelerated member access to new and
emerging technologies. In the previous two competing submissions, these technologies have been largely
provided through the Molecular Biology & Genomics Core and the Immunology Core. Services provided
have focused largely on genomic and flow cytometic technologies, and have evolved over time, continuing to
provide members with support that would be otherwise inaccessible to individual investigators. Based on our
2012 CFAR Strategic Review, the membership concluded that by integrating these cores and focusing on
the intersection of advanced immunologic and genomic technologies and the increasing computational
challenges associated with these, we could better leverage CFAR resources to serve members. These two
cores were thus merged and redefined to form a single Advanced Technologies Core (ATC). The overall
mission of the new Advanced Technologies Core is to provide access to advanced cytometric/genomic
technologies and the computational methodologies that are an increasingly challenging barrier to individual
investigators. At the current time, much of the identified need for members is in the capture of information
regarding the phenotypic and functional state of individual cells, indexing these samples, and then
capitalizing on this precious biomaterial to develop a comprehensive picture of the genomic landscape that
exists in particular disease states. To ensure that all Harvard CFAR laboratories have access to this
remarkable analytical power, this core will facilitate access to such technologies through the following aims:
1) Provide CFAR member access to state-of-the art technologies.
2) Providing user training in the above technologies, as well as computational assistance.
3) Building a virtual community using state of the art sharing and distribution tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:10408915
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10319735
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10408913
-
项目类别:
-
资助金额:$69.76万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10458737
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10305659
-
项目类别:
-
资助金额:$67.45万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of Natural Killer Cell Clearance of SIV from Lymphoid Follicles
-
批准号:10529270
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
NK cell mobilization as a pathogenic etiology of SARS-CoV-2 gastrointestinal disease
-
批准号:10626025
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
-
批准号:10408910
-
项目类别:
-
资助金额:$3.66万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
-
批准号:10451069
-
项目类别:
-
资助金额:$17.8万
-
财政年份:2021
-
负责人:Roger Keith Reeves
-
依托单位:
Natural killer cell receptor-expressing B cells as regulators of mucosal immunity in SIV infection
-
批准号:9927204
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2019
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
-
批准号:9405715
-
项目类别:
-
资助金额:$87.66万
-
财政年份:2017
-
负责人:Roger Keith Reeves
-
依托单位:
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:9187130
-
项目类别:
-
资助金额:$63.21万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Mechanisms of innate modulation of SIV reservoirs and opportunistic disease in the oral cavity
-
批准号:9117095
-
项目类别:
-
资助金额:$72.38万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Microbial and innate immune mechanisms of oral inflammation during SIV infection
-
批准号:9316584
-
项目类别:
-
资助金额:$67.54万
-
财政年份:2016
-
负责人:Roger Keith Reeves
-
依托单位:
Innate Lymphoid Cell Modulation of SIV Transmission and Pathogenesis
-
批准号:9089886
-
项目类别:
-
资助金额:$20.12万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Antigen-Specific NK Cell Memory Against SIV and SIV Vaccines
-
批准号:9078188
-
项目类别:
-
资助金额:$71.7万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Enhancing Resolution of Memory NK cells in CMV- and SIV-infected macaques
-
批准号:9001899
-
项目类别:
-
资助金额:$16.59万
-
财政年份:2015
-
负责人:Roger Keith Reeves
-
依托单位:
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control
-
批准号:8509165
-
项目类别:
-
资助金额:$26.25万
-
财政年份:2013
-
负责人:Roger Keith Reeves
-
依托单位:
Role of NK Cells in GBV-B Infection: Modeling HCV Clearance and Control
-
批准号:8607499
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2013
-
负责人:Roger Keith Reeves
-
依托单位:
Advanced Lab Technologies Core
-
批准号:10238751
-
项目类别:
-
资助金额:$35.62万
-
财政年份:2004
-
负责人:Roger Keith Reeves
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: